Angiotensin-I-converting enzyme inhibitory peptides in milk fermented by indigenous lactic acid bacteria

43Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

Background and Aim: Fermented milk can be used to produce antihypertensive peptides. Lactic acid bacteria (LAB) with its proteolytic system hydrolyze milk protein during fermentation to produce several peptides, which include antihypertensive bioactive peptides. This study aimed to investigate the ability of indigenous LAB for the production of angiotensin-I-converting enzyme inhibitory (ACE-I) peptides in fermented milk and to characterize the ACEI peptides. Materials and Methods: Reconstituted milk (11%) inoculated with ten LAB isolates, and then incubated at 37°C until it reaches pH 4.6. The evaluation was carried out for LAB count, lactic acid concentration, peptide content, and ACE-I activity. The low molecular weight (MW) peptides (<3 kDa) were identified using Nano LC Ultimate 3000 series system Tandem Q Exactive Plus Orbitrap high-resolution mass spectrometry. Results: The result showed that the ten LAB isolates were able to produce ACE-I in fermented milk with the activities in the range of 22.78±2.55-57.36±5.40%. The activity of ACE-I above 50% produced by Lactobacillus delbrueckii BD7, Lactococcus lactis ssp. lactis BD17, and Lactobacillus kefiri YK4 and JK17, with the highest activity of ACE-I produced by L. kefiri YK4 (IC50 0.261 mg/mL) and L. kefiri JK17 (IC50 0.308 mg/mL). Results of peptide identification showed that L. kefiri YK 4 could release as many as 1329, while L. kefiri JK 17 could release 174 peptides. The peptides produced were 95% derived from casein. The other peptides were from ά-lactalbumin, β-lactoglobulin, and serum amyloid A. The peptides produced consisted of 6-19 amino acid residues, with MWs of 634-2079 Dalton and detected at 317-1093 m/z. A total of 30 peptides have been recognized based on literature searches as ACE-I peptides (sequence similarity: 100%). Conclusion: L. kefiri YK4 and JK17 are the potential to be used as starter cultures to produce the bioactive peptide as ACE-I in fermented milk.

References Powered by Scopus

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

233563Citations
N/AReaders
Get full text

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

2490Citations
N/AReaders
Get full text

Food-derived peptides with biological activity: from research to food applications

965Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Metabolism Characteristics of Lactic Acid Bacteria and the Expanding Applications in Food Industry

597Citations
N/AReaders
Get full text

Probiotics in the dairy industry—Advances and opportunities

129Citations
N/AReaders
Get full text

Revisiting therapeutic and toxicological fingerprints of milk-derived bioactive peptides: An overview

44Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Rubak, Y. T., Nuraida, L., Iswantini, D., & Prangdimurti, E. (2020). Angiotensin-I-converting enzyme inhibitory peptides in milk fermented by indigenous lactic acid bacteria. Veterinary World, 13(2), 345–353. https://doi.org/10.14202/vetworld.2020.345-353

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 23

74%

Lecturer / Post doc 6

19%

Researcher 2

6%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 17

46%

Biochemistry, Genetics and Molecular Bi... 9

24%

Immunology and Microbiology 7

19%

Engineering 4

11%

Save time finding and organizing research with Mendeley

Sign up for free